Insider Cluster (2 insiders) ·Filed Jul 6, 2026

VRTX

VERTEX PHARMACEUTICALS INC / MA
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $704K total
Actionable Insight • Neutral

This cluster is non-informative. The insider sales are tiny relative to Vertex's $134B market cap and likely reflect routine diversification. Monitor upcoming quarterly earnings for any fundamental surprises; the insider activity alone provides no actionable signal.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
VRTX ▼ -0.54% at T+60d
NEUTRAL call ✗ call lost -0.54% · α vs SPY -2.26% · entry $529.59 → $526.73
Entry anchored
Jul 2, 03:59 PM ET
via exchange tick
T+1d
-1.39%
call -1.39% · α -0.91%
$522.25
settled 3mo ago
T+5d
-8.35%
call -8.35% · α -8.83%
$485.39
settled 3mo ago
T+20d
-9.91%
call -9.91% · α -9.35%
$477.10
settled 2mo ago
T+60d
-0.54%
call -0.54% · α -2.26%
$526.73
settled 4d ago

Price Chart

Loading chart...

Executive Summary

Two VRTX C-suite executives (CMO and Chief Legal Officer) sold a combined ~$704K in open-market sales over a one-week window. At a $134B market cap, this is ~0.0005% — a trivial amount that is non-informative, likely driven by personal liquidity or tax planning. No insider purchases were reported.

Key Financial Metrics

Direction
selling
Total Value
$704.0K
Insiders
2

Key Facts

  • EVP and Chief Legal Officer Liu Joy sold 828 shares at $502.71 on 2026-07-01, total $416,243.88
  • EVP and CMO Bozic Carmen sold 596 shares at $482.50 on 2026-06-26, total ~$288K
  • Total cluster value ~$704K, representing ~0.0005% of Vertex's $134B market cap
  • No insider buying in the cluster; net direction is exclusively selling
  • Both sellers are C-suite officers but the dollar amounts are immaterial relative to company size
  • No 10b5-1 plan data available, but the low frequency and small size are consistent with routine liquidity trades

Financial Impact

Total insider selling of ~$704K — less than 0.001% of market cap. Negligible economic impact.

dilution

Risk Factors

  • Insiders are selling but at trivial levels — no material risk signal from this activity
  • Historical calibration for this report type shows negative average alpha at T+20 (-0.29%), suggesting limited predictive power for routine clusters
  • No compensatory insider buying to suggest confidence in near-term outlook

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (40 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-VRTX-1783409590287
11 reports for VRTX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for VRTX — sortable, filterable
TypeNow
Jul 7, 2026
12w ago
8-K
BULLISH ★ 7/10
$522.25 $522.81▲ +0.11%▼ −1.89%$501.30 (−4.01%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$522.25 $522.81▲ +0.11%▼ −1.89%$501.30 (−4.01%)
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$529.59 $526.73▼ −0.54%▼ −2.26%$501.30 (−5.34%)
Jun 3, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$441.47 $541.69▲ +22.70%▲ +21.08%$501.30 (+13.55%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$430.05 $505.75▲ +17.60%▲ +12.87%$501.30 (+16.57%)
Mar 11, 2026
29w ago
Insider Cluster
NEUTRAL ★ 3/10
$491.96 $428.34▼ −12.93%▼ −24.45%$501.30 (+1.90%)
Feb 25, 2026
31w ago
Insider Cluster
NEUTRAL ★ 4/10
$482.92 $430.44▼ −10.87%▼ −17.82%$501.30 (+3.81%)
Feb 25, 2026
31w ago
Insider Cluster
BEARISH ★ 6/10
$482.92 $430.44▲ +10.87%▲ +17.82%$501.30 (−3.81%)
Feb 25, 2026
31w ago
Insider Cluster
NEUTRAL ★ 3/10
$482.92 $430.44▼ −10.87%▼ −17.82%$501.30 (+3.81%)
Feb 25, 2026
31w ago
Insider Cluster
NEUTRAL ★ 4/10
$482.92 $430.44▼ −10.87%▼ −17.82%$501.30 (+3.81%)
Showing 10 of 11

US Market Status

Market Open — Closes in 6h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 7, 2026